Revolving Door Of Executive Changes At Perrigo As Firm Revises Its Expectations Up
Firm Has Experienced Notable Disruption Due To Ukraine Conflict
Executive Summary
Perrigo is set to welcome a new chief financial officer and corporate security head as it rounds up a fairly successful first quarter.
You may also be interested in...
Who’s Hired? Formycon Is Latest To Swap CEO
Formycon has become the latest firm to announce a new CEO, after similar moves at Orion and Strides. Meanwhile, Gedeon Richter has made management changes and a new director has joined Coherus.
Perrigo Boosts 2022 Guidance Shifting From Changing Organization To Delivering Results
“We said we would start growing this company ... and this is the year to do it,” says CERO Murray Kessler. With nearly 11% net sales growth for its Americas business leading nearly 10% overall Q1 growth, Perrigo raises full-year guidance for net sales growth to 8% to 9%, up earlier 7% to 8%.
Perrigo Trades Rx For HRA With €1.8bn Acquisition
Perrigo has announced a deal to acquire consumer healthcare company HRA Pharma for €1.8bn. The move comes after the firm shed the majority of its prescription pharmaceuticals interests in recent years and completes its transformation into a fully self-care focused company.